Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients.

The development of diabetes mellitus (DM) after living donor kidney transplantation (KT) is a risk factor for worsening transplant kidney function, cardiac disease, and cerebrovascular disease, which may affect prognosis after KT. At our institution, all patients' glucose tolerance is evaluated...

Full description

Bibliographic Details
Main Authors: Akihiko Mitsuke, Takahiko Ohbo, Junya Arima, Yoichi Osako, Takashi Sakaguchi, Ryosuke Matsushita, Hirofumi Yoshino, Shuichi Tatarano, Yasutoshi Yamada, Hajime Sasaki, Tatsu Tanabe, Nobuyuki Fukuzawa, Hiroshi Tanaka, Yoshihiko Nishio, Enokida Hideki, Hiroshi Harada
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0287059
_version_ 1827771134661099520
author Akihiko Mitsuke
Takahiko Ohbo
Junya Arima
Yoichi Osako
Takashi Sakaguchi
Ryosuke Matsushita
Hirofumi Yoshino
Shuichi Tatarano
Yasutoshi Yamada
Hajime Sasaki
Tatsu Tanabe
Nobuyuki Fukuzawa
Hiroshi Tanaka
Yoshihiko Nishio
Enokida Hideki
Hiroshi Harada
author_facet Akihiko Mitsuke
Takahiko Ohbo
Junya Arima
Yoichi Osako
Takashi Sakaguchi
Ryosuke Matsushita
Hirofumi Yoshino
Shuichi Tatarano
Yasutoshi Yamada
Hajime Sasaki
Tatsu Tanabe
Nobuyuki Fukuzawa
Hiroshi Tanaka
Yoshihiko Nishio
Enokida Hideki
Hiroshi Harada
author_sort Akihiko Mitsuke
collection DOAJ
description The development of diabetes mellitus (DM) after living donor kidney transplantation (KT) is a risk factor for worsening transplant kidney function, cardiac disease, and cerebrovascular disease, which may affect prognosis after KT. At our institution, all patients' glucose tolerance is evaluated perioperatively by oral glucose tolerance tests (OGTTs) at pre-KT, and 3, 6, and 12 month (mo.) after KT. We analyzed the insulinogenic index (ISI) and homeostasis model assessment beta cell (HOMA-β) based on the immunoreactive insulin (IRI) levels to determine how glucose tolerance changed after KT in 214 patients who had not been diagnosed with DM before KT. In addition, we analyzed the body mass index (BMI) which may also influence glucose tolerance after KT. The concentration of tacrolimus (TAC) in blood was also measured as the area under the curve (AUC) to examine its effects at each sampling point. The preoperative-OGTTs showed that DM was newly diagnosed in 22 of 214 patients (10.3%) who had not been given a diagnosis of DM by the pre-KT fasting blood sugar (FBS) tests. The glucose tolerance was improved in 15 of 22 DM patients at 12 mo. after KT. ISI and IRI deteriorated only at 3 mo. after KT but improved over time. There was a trend of an inverse correlation between HOMA-β and TAC-AUC. We also found inverse correlations between IRI and an increase in BMI from 3 to 12 mo. after KT. Early corticosteroid withdrawal or the steroid minimization protocol with tacrolimus to maintain a low level of diabetogenic tacrolimus and BMI decrease after KT used by our hospital individualizes lifestyle interventions for each patient might contribute to an improvement in post-KT glucose tolerance.
first_indexed 2024-03-11T12:50:19Z
format Article
id doaj.art-0f18739c3b714f4bb6465e0e6bd7a607
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-03-11T12:50:19Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-0f18739c3b714f4bb6465e0e6bd7a6072023-11-04T05:33:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-011810e028705910.1371/journal.pone.0287059Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients.Akihiko MitsukeTakahiko OhboJunya ArimaYoichi OsakoTakashi SakaguchiRyosuke MatsushitaHirofumi YoshinoShuichi TataranoYasutoshi YamadaHajime SasakiTatsu TanabeNobuyuki FukuzawaHiroshi TanakaYoshihiko NishioEnokida HidekiHiroshi HaradaThe development of diabetes mellitus (DM) after living donor kidney transplantation (KT) is a risk factor for worsening transplant kidney function, cardiac disease, and cerebrovascular disease, which may affect prognosis after KT. At our institution, all patients' glucose tolerance is evaluated perioperatively by oral glucose tolerance tests (OGTTs) at pre-KT, and 3, 6, and 12 month (mo.) after KT. We analyzed the insulinogenic index (ISI) and homeostasis model assessment beta cell (HOMA-β) based on the immunoreactive insulin (IRI) levels to determine how glucose tolerance changed after KT in 214 patients who had not been diagnosed with DM before KT. In addition, we analyzed the body mass index (BMI) which may also influence glucose tolerance after KT. The concentration of tacrolimus (TAC) in blood was also measured as the area under the curve (AUC) to examine its effects at each sampling point. The preoperative-OGTTs showed that DM was newly diagnosed in 22 of 214 patients (10.3%) who had not been given a diagnosis of DM by the pre-KT fasting blood sugar (FBS) tests. The glucose tolerance was improved in 15 of 22 DM patients at 12 mo. after KT. ISI and IRI deteriorated only at 3 mo. after KT but improved over time. There was a trend of an inverse correlation between HOMA-β and TAC-AUC. We also found inverse correlations between IRI and an increase in BMI from 3 to 12 mo. after KT. Early corticosteroid withdrawal or the steroid minimization protocol with tacrolimus to maintain a low level of diabetogenic tacrolimus and BMI decrease after KT used by our hospital individualizes lifestyle interventions for each patient might contribute to an improvement in post-KT glucose tolerance.https://doi.org/10.1371/journal.pone.0287059
spellingShingle Akihiko Mitsuke
Takahiko Ohbo
Junya Arima
Yoichi Osako
Takashi Sakaguchi
Ryosuke Matsushita
Hirofumi Yoshino
Shuichi Tatarano
Yasutoshi Yamada
Hajime Sasaki
Tatsu Tanabe
Nobuyuki Fukuzawa
Hiroshi Tanaka
Yoshihiko Nishio
Enokida Hideki
Hiroshi Harada
Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients.
PLoS ONE
title Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients.
title_full Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients.
title_fullStr Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients.
title_full_unstemmed Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients.
title_short Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients.
title_sort low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in japanese patients
url https://doi.org/10.1371/journal.pone.0287059
work_keys_str_mv AT akihikomitsuke lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT takahikoohbo lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT junyaarima lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT yoichiosako lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT takashisakaguchi lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT ryosukematsushita lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT hirofumiyoshino lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT shuichitatarano lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT yasutoshiyamada lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT hajimesasaki lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT tatsutanabe lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT nobuyukifukuzawa lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT hiroshitanaka lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT yoshihikonishio lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT enokidahideki lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients
AT hiroshiharada lowdosetacrolimusexposureandearlysteroidwithdrawalwithstrictbodyweightcontrolcanimprovepostkidneytransplantglucosetoleranceinjapanesepatients